Search Hanover.com
Display search count
|
|
No business is immune to cyber risk, but with connected medical devices and records, the stakes for life sciences companies are even higher. With Hanover Fusion, The Hanover is ready to help agents mitigate these risks for their life sciences customers. Article 
|
|
|
|
|
The difference you make as an independent agent Learn the unique advantage independent agents have in the insurance market place - and what factors impede them from fully capitalizing on it. Article 
|
Busting common myths about service centers Learn the truth about many myths regarding carrier service centers, and why partnering with a service center may be the best way you can positively impact your agency's productivity and realize a long-term growth strategy. Article 
|
The talent environment is changing. Are you ready? See statistics that illustrate the staffing challenges today's independent insurance agents face, and learn how The Hanover can help optimize agency efficiency. Infographic 
|
How top independent insurance agents can maximize their time See how resilient insurance agents leverage partner-carrier resources to run efficient, effective business operations. Article 
|
Business as usual won’t work in a hard market With more of the standard auto and home market being commoditized, the future of independent agents is more with their complex accounts that value consultation and risk education. This article shares four tips to help agents like you prioritize where you best spend your time and set up their businesses for long-term success in a dynamic market. Article 
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The growing use and emerging risks of exoskeleton technology As the adoption of exoskeleton technology increases, so do the associated risks for the companies that make it. For insurance agents, this represents a strategic opportunity, as organizations across technology and life sciences turn to agents to understand their evolving exposures and secure coverage tailored to their high-growth, innovative operations. Article 
|
|
|
|
|
Safeguarding the research of life sciences organizations In the development of new medical treatments, drugs, and procedures, life sciences organizations may rely on research animals to meet the FDA approval requirements. When working with these organizations, agents should consider a carrier with deep expertise in life sciences, can provide the targeted coverage and risk management services these organizations need to successfully conduct their work safely. Article 
|
